These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 8584657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The canine model of human cognitive aging and dementia: pharmacological validity of the model for assessment of human cognitive-enhancing drugs.
    Studzinski CM, Araujo JA, Milgram NW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):489-98. PubMed ID: 15795058
    [Abstract] [Full Text] [Related]

  • 3. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging.
    Araujo JA, Studzinski CM, Milgram NW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):411-22. PubMed ID: 15795050
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases.
    Knoll J.
    J Neural Transm Suppl; 1993 Mar; 40():69-91. PubMed ID: 8294902
    [Abstract] [Full Text] [Related]

  • 10. The role of human cognitive neuroscience in drug discovery for the dementias.
    Wesnes KA, Edgar CJ.
    Curr Opin Pharmacol; 2014 Feb; 14():62-73. PubMed ID: 24565014
    [Abstract] [Full Text] [Related]

  • 11. A report from the 13th International Conference on Alzheimer's Disease and Related Disorders (ICAD) (July 10-15, 2010-Honolulu, Hawaii, USA).
    Rabasseda X.
    Drugs Today (Barc); 2010 Nov; 46(11):875-87. PubMed ID: 21225026
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic actions of L-deprenyl in dogs: a model of human brain aging.
    Ruehl WW, Neilson J, Hart B, Head E, Bruyette DS, Cummings BJ.
    Adv Pharmacol; 1998 Nov; 42():316-9. PubMed ID: 9327904
    [No Abstract] [Full Text] [Related]

  • 14. The rate of decline in function in Alzheimer's disease and other dementias.
    Mitnitski AB, Graham JE, Mogilner AJ, Rockwood K.
    J Gerontol A Biol Sci Med Sci; 1999 Feb; 54(2):M65-9. PubMed ID: 10051857
    [Abstract] [Full Text] [Related]

  • 15. [Clinical-therapeutic study of dementia in people with Down syndrome and the effectiveness of donepezil in this population].
    Boada-Rovira M, Hernández-Ruiz I, Badenas-Homiar S, Buendía-Torras M, Tárraga-Mestre L.
    Rev Neurol; 1999 Feb; 41(3):129-36. PubMed ID: 16047294
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results.
    Burke WJ, Ranno AE, Roccaforte WH, Wengel SP, Bayer BL, Willcockson NK.
    J Am Geriatr Soc; 1993 Apr; 41(4):367-70. PubMed ID: 8463521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.